e-learning
resources
Milan 2017
Monday, 11.09.2017
Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of obstructive sleep apneao–induced intermittant Hypoxia on Non Alcoholic Fatty liver.
S. Saraç (Istanbul, Turkey)
Source:
International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Session:
Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Session type:
Thematic Poster
Number:
2316
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Saraç (Istanbul, Turkey). The influence of obstructive sleep apneao–induced intermittant Hypoxia on Non Alcoholic Fatty liver.. 2316
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011
Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Chronic intermittent hypoxia induces features of non alcoholic fatty liver disease (NAFLD) and modifies adipose tissue characteristics in lean mice
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017
Fatty airways: implications for obstructive disease
Source: Eur Respir J, 54 (6) 1900857; 10.1183/13993003.00857-2019
Year: 2019
Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Hypoxic and non-hypoxic obstructive sleep disordered breathing. Effect on cytotoxic lymphocytes and metabolic parameters
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Relationship between OSA and non-alcoholic fatty liver disease
Source: ERS Conference
Year: 2015
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea
Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Year: 2013
Effects of obstructive sleep apnoea on systemic inflammation and adipose tissue expression of CD40, MKK4 and JNK
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014
Sleep in chronic obstructive disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=325
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept